Skip to main content
Log in

Enhancement of anti-tumour effect by cooling

  • Published:
International Journal of Biometeorology Aims and scope Submit manuscript

Abstract

Protamine sulphate B.P. and Armeen DM16D acetate both inhibit a specific coagulative factor produced by malignant tumours. This factor aids the invasiveness of tumours, and its inhibition is known to retard tumour growth.Protamine and Armeen both had a greater effect on an implanted subcutaneous mouse tumour, Sarcoma 180, at 9° to 10°C than at 24° to 25°C.

Zusammenfassung

Sowohl Protaminsulfat als auch Armeen DM16D Acetat hemmen einen spezifischen gerinnung verursachenden Faktor, der von malignen Tumoren gebildet wird. Dieser Faktor erleichtert das infiltierende Wachstum der Tumoren und seine Hemmung verzögert es. Die Wachstumshemmung von subkutan implantierten Sarcoma 180 Tumoren durch Protamin und Armeen war grösser in Mäusen in der Kälte bei 9° bis 10°C als bei 24° bis 25°C.

Resume

Le sulfate de protamine et l'acétate d'armeen DM16D sont les inhibiteurs d'un principe coagulant spécifique produit par les tumeurs malignes. Ce principe facilite le développement et l'infiltration de la tumeur dans les tissus et son inhibition les ralentit. L'action inhibitive de la protamine et de l'armeen sur des tumeurs (Sarcoma 180) implantées sous la peau de souris fut plus efficace au froid (9° à 10°C) que par 24° à 25°C.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • BOGGUST, W.A., O'BRIEN, D.J., O'MEARA, R.A.Q. and THORNES, R.D. (1963): The coagulative factors of normal human and human cancer tissue. Irish J.Med.Sci., 447: 131–144.

    Google Scholar 

  • GLASER, E.M. and AUSTIN, J.P. (1969): Effect of protamine sulphate and environmental temperature on mouse sarcoma 180. Nature (Lond.), 221: 87–88.

    Google Scholar 

  • HUGHES, L.E. (1964): Treatment of malignant disease with protamine sulphate. Lancet, 1: 408–409.

    Google Scholar 

  • KRASNOW, S. (1969): Physiological chilling as a possible factor in mortality from neoplasia. Int.J.Biometeor., 13: 87–92.

    Google Scholar 

  • O'MEARA, R.A.Q. (1958): Coagulative properties of cancer. Irish J.Med.Sci., 394: 474–479.

    PubMed  Google Scholar 

  • O'MEARA, R.A.Q. and O'HALLORAN, M.J. (1963): Protamine derivatives in the treatment of advanced carcinoma of the breast. Lancet, ii: 613–614.

    Google Scholar 

  • O'MEARA, R.A.Q. and THORNES, R.D. (1961): Some properties of the cancer coagulative factor. Irish J.Med.Sci., 423: 106–112.

    PubMed  Google Scholar 

  • THORNES, R.D. and O'MEARA, R.A.Q. (1961): A method of detecting and estimating inhibitors of the cancer coagulative factor. Irish J.Med.Sci., 428: 361–365.

    PubMed  Google Scholar 

  • TROMP, S.W. (1968): Psychosomatic aspects of cancer. Medical News Research Review, May 24: 7.

    Google Scholar 

  • WRIGHT, J.E.C. (1968): Clinical trial of protamine in the treatment of malignant diseases. Brit.J.Cancer, 22: 415–421.

    PubMed  Google Scholar 

  • YOUNG, S. (1968): Effect of temperature on the production of induced mammary tumours. Nature (Lond.), 219: 1264–1265.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Austin, J.P., Glaser, E.M. Enhancement of anti-tumour effect by cooling. Int J Biometeorol 13, 183–187 (1969). https://doi.org/10.1007/BF01552739

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01552739

Keywords

Navigation